US 11,865,229 B2
Apparatuses and methods for producing enriched fibrillated tissue matrices
Timothy Ganey, Tampa, FL (US)
Assigned to Jupiter Biologics, LLC, Tulsa, OK (US)
Filed by Timothy Ganey, Tampa, FL (US)
Filed on Dec. 28, 2020, as Appl. No. 17/135,762.
Application 16/409,934 is a division of application No. 16/034,487, filed on Jul. 13, 2018, granted, now 10,286,109, issued on May 14, 2019.
Application 17/135,762 is a continuation of application No. 16/409,934, filed on May 13, 2019, granted, now 10,874,765.
Claims priority of provisional application 62/533,648, filed on Jul. 17, 2017.
Prior Publication US 2021/0138115 A1, May 13, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/36 (2006.01); A61L 27/54 (2006.01)
CPC A61L 27/3691 (2013.01) [A61L 27/36 (2013.01); A61L 27/54 (2013.01); A61L 2300/414 (2013.01); A61L 2300/426 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method, comprising:
placing a carrier liquid into a pressure vessel;
introducing tissue into the carrier liquid;
pressurizing the carrier liquid and the tissue within the pressure vessel to a critical pressure;
selectively controlling a temperature within the pressure vessel so as to preserve biological components of the tissue during a boiled liquid expanding vapor explosion (BLEVE) process; and
depressurizing the pressure vessel to trigger the BLEVE process to produce a fibrillated tissue matrix and a vaporized fluid comprising at least a portion of the biological components.